Back to News
Market Impact: 0.2
UK digital pathology provider Source BioScience chooses Sectra to enable seamless pathology collaboration across the NHS
Source: PR Newswire
Healthcare & BiotechCybersecurity & Data PrivacyTechnology & Innovation
Sectra signed an agreement with UK-based Source BioScience to provide its advanced medical-imaging sharing and collaboration workflow service. The contract expands Sectra's presence in the UK healthcare IT market and supports its imaging and cybersecurity offerings, though no financial terms or expected revenue contribution were disclosed.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.25
Ticker Sentiment
SECT.B0.55
More News
- AI’s Grip on Financial Markets Was Never Clearer on the Way Down
- Tech stock rout, driven by US AI fears, continues in Asian trading
- Asian Markets Tally Losses From Worsening Global Rout
- Magnificent 7 loses $1 trillion. The most eye-popping stats from Thursday's tech stock plunge
- Wall Street’s best post-midterm rally in 44 years lasted just one day—then $3 trillion vanished as chip stocks plunged over AI fears
- Moderna raises 2026 outlook as CEO says newer vaccines are gaining traction